DOW/ US2605571031 /
21/05/2024 10:48:11 | Chg. - | Volume | Bid13:35:01 | Ask13:35:01 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
54.55EUR | - | 400 Turnover: 22,080.71 |
51.92Bid Size: 193 | 52.33Ask Size: 192 | 37.26 bill.EUR | - | - |
GlobeNewswire
13/02
Cingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff Ervin to its Board of Directors
GlobeNewswire
22/01
60 Degrees Pharma Plans Pivotal Babesiosis Study with Tafenoquine Following Jan 17 FDA Meeting
GlobeNewswire
16/11/2023
Dow Jones Appoints Global Agency Partners to Accelerate Marketing Transformation and Subscription Gr...
GlobeNewswire
11/10/2023
Dow Jones Risk & Compliance Completes ISAE 3000 Assurance for Ninth Consecutive Year
GlobeNewswire
06/09/2023
60 Degrees Pharmaceuticals to Participate in H.C. Wainwright 25th Annual Global Investment Conferenc...
GlobeNewswire
17/11/2021
Gildan Included on the 2021 Dow Jones Sustainability Index for the Ninth Consecutive Year